DOBŠÁK, Petr, Vladimír SOŠKA, Ondřej SOCHOR, Jiří JARKOVSKÝ, Marie NOVÁKOVÁ, Martin HOMOLKA, Miroslav SOUČEK, Petra PALANOVÁ, Francisco LOPEZ-JIMENEZ and Kohji SHIRAI. Increased Cardio-ankle Vascular Index in Hyperlipidemic Patients without Diabetes or Hypertension. Journal of Atherosclerosis and Thrombosis. Tokyo: Japan Atherosclerosis Society, 2015, vol. 22, No 3, p. 272-283. ISSN 1340-3478.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Increased Cardio-ankle Vascular Index in Hyperlipidemic Patients without Diabetes or Hypertension
Authors DOBŠÁK, Petr (203 Czech Republic, belonging to the institution), Vladimír SOŠKA (203 Czech Republic, guarantor, belonging to the institution), Ondřej SOCHOR (203 Czech Republic), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Marie NOVÁKOVÁ (203 Czech Republic, belonging to the institution), Martin HOMOLKA (203 Czech Republic), Miroslav SOUČEK (203 Czech Republic, belonging to the institution), Petra PALANOVÁ (203 Czech Republic, belonging to the institution), Francisco LOPEZ-JIMENEZ (840 United States of America) and Kohji SHIRAI (392 Japan).
Edition Journal of Atherosclerosis and Thrombosis, Tokyo, Japan Atherosclerosis Society, 2015, 1340-3478.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Japan
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.411
RIV identification code RIV/00216224:14110/15:00085181
Organization unit Faculty of Medicine
UT WoS 000352271200008
Keywords in English Cardio-ankle vascular index; Combined hyperlipidemia; Hypercholesterolemia
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 27/1/2016 12:01.
Abstract
Aim: The cardio-ankle vascular index (CAVI) is a sensitive non-invasive marker of arterial stiffness and atherosclerosis. The aim of this work was to compare the CAVI values in patients with dyslipidemia (without diabetes mellitus and hypertension) and healthy controls. Methods: A Total 248 subjects with dyslipidemia (104 men, 144 women), 55.0 (95% CI 30-70) years of age with combined hyperlipidemia or primary hypercholesterolemia and 537 healthy controls (244 men, 293 women) 40.0 (95% CI 26-62) years of age were included in this study. Fasting blood samples were collected to measure the serum total cholesterol, triglyceride, HDL-cholesterol and apolipoprotein A1 and B levels. The LDL cholesterol level was also calculated, and the CAVI was measured using the VaSera (R) 1500 system. Results: The CAVI values were significantly higher in the dyslipidemic patients (8.08, 95% CI 6.00-10.05) than in the controls (7.11, 95% CI 5.77-9.05; p<0.01). In addition, the CAVI values were elevated in both subgroups of patients with hypercholesterolemia (7.95, 95% CI 5.85-6.90; p<0.01) and combined hyperlipidemia (8.30, 95% CI 6.60-10.15; p<0.01) in comparison with those observed in the controls. After adopting the propensity score method in order to balance the confounding factors (age, gender, body mass index) and adjust the analysis for diastolic blood pressure, the CAVI values in the dyslipidemic patients remained significantly high (7.78, 95% CI 5.80-9.69) compared to that observed in the controls (7.31, 95% CI 5.44-9.35; p<0.001). However, the CAVI values did not differ significantly between the controls and both subgroups of dyslipidemic patients (primary hypercholesterolemia, combined hyperlipidemia). Conclusions: The present findings demonstrated that dyslipidemia increases the CAVI values in comparison to that seen in healthy subjects.
PrintDisplayed: 1/8/2024 00:24